2,5-dimethyl-3-[(4-methyl-1-piperidinyl)methyl]benzaldehyde, 95.0%, 1g

4-(3-CHLORO-PROPYL)-4-CYANO-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 90.0%, 1g

3-(4-Bromophenyl)propan-1-amine, 95%, 5g

Methyl 2-(2,5-dioxoimidazolidin-4-yl)acetate, 95.0%, 100mg

3-(Bromoacetyl)pyridine Hydrobromide>98.0%(HPLC)(T)5g

(2-Chloro-4-methoxyphenyl)methanamine hydrochloride, 95%, 100mg

5-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1H-1,2,3-benzotriazole-6-carboxamide hydrochloride, 95+%, 50mg

4-ETHOXY-N-(5-NITROTHIAZOL-2-YL)BENZAMIDE, 95%, 10mg

3,4-Dimethoxybenzoylacetonitrile, 95.0%, 5g

N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Hydrochloride), 97%, 10mg

2-(2-Aminothiazol-4-yl)acetic acid hydrochloride, 95.0%, 100g

BSTFA [=N,O-Bis(trimethylsilyl)trifluoroacetamide] [for Gas Chromatography]>95.0%(GC)5mL

3,4-Dichloro-5-(chlorosulfonyl)benzoic acid, 95+%, 2.5g